Clinical Trial Update: Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

View source ↗

Summary

Clinical trial update on a microfluidic-based liquid biopsy platform to prognosticate recurrent/metastatic head and neck cancers using NK cell IFN-γ expression …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Head and Neck Cancers- Squamous Cell, Head and Neck Cancer Metastatic | Status: RECRUITING